Altered Gray Matter Volume and School Age Anxiety in Children Born Late Preterm - 22/10/14
, Deanna M. Barch, PhD 1, 3, 4, 5, Chad M. Sylvester, MD, PhD 1, David Pagliaccio, MS 5, Michael P. Harms, PhD 1, Kelly N. Botteron, MD 1, 3, Joan L. Luby, MD 1Abstract |
Objectives |
To determine if late preterm (LP) children differ from full term (FT) children in volumes of the cortex, hippocampus, corpus callosum, or amygdala and whether these differences are associated with anxiety symptoms at school-age.
Study design |
LP children born between 34 and 36 weeks gestation and FT children born between 39 and 41 weeks gestation from a larger longitudinal cohort had magnetic resonance imaging scans at school-age. Brain volumes, cortical surface area, and thickness measures were obtained. Anxiety symptoms were assessed using a structured diagnostic interview annually beginning at preschool-age and following the magnetic resonance imaging.
Results |
LP children (n = 21) had a smaller percentage of total, right parietal, and right temporal lobe gray matter volume than FT children (n = 87). There were no differences in hippocampal, callosal, or amygdala volumes or cortical thickness. LP children also had a relative decrease in right parietal lobe cortical surface area. LP children had greater anxiety symptoms over all assessments. The relationship between late prematurity and school-age anxiety symptoms was mediated by the relative decrease in right temporal lobe volume.
Conclusions |
LP children, comprising 70% of preterm children, are also at increased risk for altered brain development particularly in the right temporal and parietal cortices. Alterations in the right temporal lobe cortical volume may underlie the increased rate of anxiety symptoms among these LP children. These findings suggest that LP delivery may disrupt temporal and parietal cortical development that persists until school-age with the right temporal lobe conferring risk for elevated anxiety symptoms.
Le texte complet de cet article est disponible en PDF.Keyword : CAPA, FT, GA, GAD, LP, MDD, MRI, PAPA, PTSD, VAN
Plan
| Supported by the National Institute of Mental Health (MH64769 [to J.L.] and RO1 MH090786 [to J.L., D.B., and K.B.]). C.R. was supported by the National Center for Advancing Translational Sciences (UL1 TR000448 sub award KL2 TR000450). C.S. was supported by the National Institute of Mental Health (RO1 MH090786-03S1). J.L. received funding from the Sidney R. Baer, Jr Foundation and the CHADS Coalition, and has served as a consultant for the Food and Drug Administration. D.B. has received consultant compensation from Pfizer, Amgen, and Roche. The other authors declare no conflicts of interest. |
Vol 165 - N° 5
P. 928-935 - novembre 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
